Our aim to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Neuroscience and Brain Disorders.
To provide a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent solutions adopted in the fields of Neuroscience and Brain Disorders.
Abstract Submission Deadline
June 25, 2022
Early Bird Registration
May 06, 2022
December 08-10, 2022
Editorial Board Member at Mar Neurology Medical Journal USA
Prof. Dr. Melchor Rodrigo is a World Renowned American Neurologist, RESEARCHER AND PROFESSOR. Chair of MS in the World Congress of Controversies in Neurology in Varsovia, Madrid and London. Discoverer of Lyme Disease in Argentina, wrote two ebooks about it. He has a very strong académic background, númerous publications in many scientífic journals. He's a reviewer in 4 Medical journals.
Institute of Occupational Medicine UK
Prof. Dr. Lang Tran works at the Institute of Occupational Medicine where he is the principal scientist in Computational Toxicology. He is involved extensively in the field of particle and fibre toxicology, air pollution and nanotoxicology, He is the coordinator and participants of several FP7 and H2020 projects of the potential health effects of engineered (bio)nanomaterials. He is currently working on the cellular and molecular mechanisms of Alzheimer’s and Parkinson’s disease. Lang Tran is a Honorary Professor at Heriot Watt University (UK) and Tor Vergata University (IT).
Ionian University Greece
Prof. Panagiotis Vlamos, Full Professor, Department of Informatics, Ionian Universityand Director of the Bioinformatics and Human Electrophysiology Laboratory (BiHELab). He has authored more than 200 papers in peer-reviewed journals and conference proceedings as well as 16 educational books. The topics of his papers are Mathematical Modelling, Applied and Discrete Mathematics as well as Bioinformatics. His main research interestis to help bridge the translational gap from data to models and from models to drug discovery and personalized therapy by developing quantitative deterministic approaches to biological and clinical problems by utilizing high-performance computing. He is the founder of the series of the World Congresses GeNeDis (“Genetics, Geriatrics and Neurodegenerative Diseases Research”), organized every two years starting from 2014. He is the editor of the Handbook of Computational Neurodegeneration that will be published by Springer International Publishing.
Translational Medicine NeuroscienceBelgium
Prof. Dr. Maria Burian, MD, PhD, MBA Translational Medicine Neuroscience, UCB Biopharma SRL Dr. Maria Burian is a board-certified Clinical Pharmacologist with medical training completed in Germany and USA. She has been working in the field of neuroscience for more than 20 years. In her previous academic and industry positions at Kerckhoff Heart Center (Bad Nauheim), Medical School Goethe University (Frankfurt), Nuvo Pharmaceuticals Inc (Toronto), Grunenthal Group (Aachen) and her current position as a Director Translational Medicine Neuroscience (Braine- l’Alleud), her research interest is in application of biomarker and translational tools in clinical research and medical practice of complex diseases, including neurodegenerative diseases.
National Institute of Republic of Serbia Serbia
Prof. Dr. Jelena Podgorac Research Associate – Department of Neurophysiology, Institute for Biological Research at National Institute of Republic of Serbia
University of Florence Italy
Prof. Annamaria Morelli graduated in Biological Sciences in 1991 at the University of Florence (Italy), where she also received her PhD degree in Functional and Neoplastic Endocrine Morphology and Post graduate degree in Medical Genetics. She worked at the University of Florence as Assistant Professor of Endocrinology and Human Anatomy since 2005 up to 2015, when she obtained her current position as Associate Professor of Human Anatomy. Current main research fields cover: neuro developmental studies in primary cultures of human neuro blasts from basal fore brain; differentiation and biological regulation of human hypothalamic GnRH-secreting neurons; neuroendocrine dysfunction, adipose tissue dys function, liver, lung and skeletal muscle morpho functional changes in a high-fatdiet-induced animal model of metabolic syndrome.She is Author of 115 scientific publications in peer reviewed International Journals
University of Padova Italy
Prof. Dr. Camillo Porcaro, Associate Professor at the Department of Neuroscience & Padova Neuroscience Center (PNC), University of Padova, Padova, Italy. Camillo Porcaro, after his PhD in Neuroimaging, at the University of Chieti-Pescara (Italy) in 2008, moved to the University of Birmingham for a post-doc on multimodal brain imaging. In 2011, he joined the Institute of Neuroscience, Newcastle University, after being awarded a highly competitive independent research position. In 2012, he moved back to Italy, where he has held an Independent Research Position at the ISTC –CNR, Rome, Italy. In 2014 and 2015, he was invited as Visiting Professor at the Department of Health Sciences and Technologies ETH, Zurich, Switzerland. From 2016 to 2020, he has also been Visiting Professor at the Department of Human Kinesiology, KU Leuven, Belgium. Since 2015, he is Adjunct Professor at the Department of Information Engineering – Università Politecnica delle Marche, Ancona. In 2021, he got his actual position as Associate Professor at the Department of Neuroscience & Padova Neuroscience Center (PNC), University of Padova, Italy. I have published around 100 full papers in international neuroscientific journals.
Howard Brain Sciences Foundation USA
Dr. Zoï Kapoula PhD./HDR, EMBA, Research Director at the CNRS, in the field of cognitive Neurosciences, leader of the IRIS CNRS lab specialized in the neuro-physiopathology of eye movements; their interaction with vision, perception, cognition, body equilibrium, and posture. Works on dyslexia, strabismus, tinnitus, vestibular deficits, vertigo, ageing, cognitive impairment and dementia in humans. She teaches eye movement control in neuroscience masters, orthoptics and optometry. She patented the REMOBI & AIDEAL technologies, founded Orasis-Ear (orasis-ear.com) spinoff of the CNRS, that brings innovations to health professionals. She created a national network on Art and Neurosciences, a school on transdisciplinarity and published books
Biomedical Sciences- Director AESTHETICS INC USA
Prof. Dr. Dario Furnari is a Physiotherapist, kynesiologist, Spinologist, Activity Coordinator, Exercise Physiology and Spa Therapist, Physiologyan aesthetic sports masseur, and instructor and expert in postural gymnastics, psychology and psychomotion for the elderly and special children or with learning disabilities. He is also a Coach and athletic trainer of various sports (football, swimming, volleyball, basketball, hockey, tennis, swimming) He is also a Prof. in Human Movement Anatomy, PhD in Applied Biomedical Sciences , done Spa manager, research in neuro rehabilitation and kinesiology ,doctor of the human movement sciences specialist in aesthetic gymnastics, weight-loss and pre and post natal, doctor of massage and physiotherapy, specialist in neuro rehabilitation, Osteopathy, Psicomotricist, aesthetic and lymphatic drainage. The lines of research on which he has worked at the University of Catania, Department of Biotechnology and Biomedical Sciences, section of applied physiology and kinesiology and motion control.
Co-founder and Cso Pockit Diagnostics Ltd UK
Dr. Edoardo Gaude has a background in Biochemistry and Biotechnology, acquired during his BSc and MSc at the San Raffaele University in Milan, Italy. Edoardo continues his career as a Metabolomics and Mass Spectrometry Specialist at the MRC Cancer Unit in Cambridge, UK, where he conducted several collaborative projects on biomarker discovery for a wide range of diseases including ischemia, cancer, neuroinflammation, and rare metabolic disorders. He then enrolled in a PhD programme in Oncology at the University of Cambridge (UK), where he studied the metabolic dependencies of cancer cells, with a focus on mitochondrial metabolism and hypoxia. After his PhD, Edoardo moved to the industry sector where he worked as a Biomarker Research Scientist at Owlstone Medical. Edoardo then co-founded Pockit diagnostics Ltd, where he is leading the scientific output of the company since 2018. During his scientific career, Edoardo published over 40 original research articles and reviews, and contributed to the filing of 3 international patents.
Boston Children’s Hospital USA
Dr. Ziyan Wu received her Ph.D. in 2020 from New Jersey Institute of Technology, NJ, USA. She has extensive research experience evaluating the structural and functional organization in the human brain using structural MRI/fMRI/DTI and functional near-infrared spectroscopy data. Dr. Wu is currently working as a Research Fellow in the Biobehavioral Pediatric Pain (BPP) Lab, Department of Psychiatry and Behavioral Sciences at Boston Children’s Hospital, MA, USA. She is involved in studies examining the biobehavioral and neural mechanisms contributing to chronic postsurgical pain, as well as pain treatment response in adolescents and adults.
University of Pisa Italy
Sara De Vincentiis is a PhD student at the University of Pisa, Italy. She has a background in Molecular and Cellular Biology, acquired during her BSc and MSc. During her PhD she focused on neurobiology, investigating the effects of extremely low mechanical forces on neuronal growth from both morphological and functional perspectives. Her studies highlighted a unified and well-conserved mechanism across development to regulate neurogenesis and cell maturation. Moreover, as PhD visiting student at the Institute of Photonic Sciences, (Spain) she started to verify the molecular mechanisms underlying the phenomenon. Her findings seem particularly promising with the perspective of the use of mechanical stimulation for therapeutic applications.
University of Pisa Italy
Alessandro Falconieri (Post Doc) has his expertise in the field of molecular biology, nanotechnologies and neuro-mechanobiology. His study of axonal growth following mechanical stimulation proposes a new model of neuritic development based on the establishment of a complex dialogue between local phenomena (i.e. axonal transport and local translation). The model based on this "cross-talk" came from his PhD work which ended in June 2021. In the next few months, he will investigate the molecular pathways activated by tension (with particular focus on signal transduction) as well as the mechanisms of repair and recovery following prolonged stimulation. The prospect of exploiting mechanical stimulation to accelerate the rate of axonal outgrowth is very intriguing as it would give the possibility of proposing a new therapeutic target for the treatment of neurons damaged following injury or disease.
Codiak Biosciences USA
Dr. Shil Patel Started career in industry as a bench scientist at Merck Research Labs in the U.K. and initially trained to develop and optimize primary and secondary binding and functional screening assays for CNS-targeted small molecules using homogenate binding and autoradiography techniques. Selected lead candidates were subsequently assessed using ex-vivo and in-vivo radioligand binding techniques. molecular techniques including behavioral assays, HPLC, PCR and cell culture procedures leading to a role in developing the biological assays used to identify and validate neuropsychiatric disorder-related molecular targets. Ultimately involved in 3 programs that successfully led to marketed drugs. Having transferred to Merck's then newly formed Imaging Research Group in the U.S., the previous experience using low energy radioisotopes was applied and extended to now discover, optimize and develop novel positron emission and to study the preclinical biological and pharmacological profiles of these radiolabeled imaging biomarkers using PET, primarily in the area of Neuroscience. In this role, I was part of a prolific team that developed and implemented in-vitro and in-vivo (invasive and non-invasive) protocols in mammals and mammalian tissues (mouse, rat, non-human primate) to identify and validate biological models of CNS and oncology-based disorders using novel and existing PET radioligands. The team is associated with successfully discovering and characterizing at least 21 novel CNS PET ligands, a large percentage of which have been utilized in human studies. On moving to Biogen in 2011, established a preclinical imaging group from the ground up starting with 4 scientists and ending in 20 full-time employees. This additionally required building out the infrastructure culminating in a functional group with PET/CT, SPECT/CT, MRI (7 and 9.4T), optical and ultrasound capabilities. A pharmacology sub-team was also added to help characterize and validate imaging data using immunohistochemistry, radioligand binding, [homogenate, cell, whole-body and tissue section autoradiography (ARG) and microARG] to enable decision-making in the therapeutic areas of neurology, immunology and hemophilia and, moreover involving small molecule, monoclonal antibody and ASO therapeutics. During this tenure I was involved in 3 programs that have led to marketed drugs at Biogen with successful execution of a SPECT imaging-paradigm that allowed visualization of a full-length Ab antibody to amyloid plaques in transgenic animals as well as initiating preclinical studies with a novel a-synuclein antibody using a surrogate imaging biomarker to track disease progression and PK/PD based on experience gained at Merck. The initial preclinical work led to the successful execution of a pilot FIM study in PD patients versus controls that mirrored changes observed in PD transgenic mouse models. After the tenure at Biogen, a moved to Eisai in Andover, MA leading a smaller group of imaging scientists utilizing the de-risking approaches honed at Merck and Biogen to help drive Eisai programs in immune-oncology and Neuroscience before moving to the current role as head of Translational Imaging and Pathology at Codiak Biosciences where these imaging-based approaches to drive exosome therapeutics towards the clinic.
Henan University China
Prof. Wang Enguo, male, born in October 1966, hua County, Henan province. He is currently the doctoral supervisor of Henan University, the distinguished professor of Henan Province, the deputy director of the Key Laboratory of Psychology and Behavior of Henan Province, the academic and technical leader of The Education Department of Henan Province, and the outstanding scholar of philosophy and social sciences of Henan Province. Chinese psychologist accredited by The Chinese Psychological Society, Director of the General and Experimental Psychology Society of the Chinese Psychological Society, His work has been published in Research in Developmental Disabilities, Journal of Learning Disabilities, Journal of Neurology and Neurology Neuroscience has published 11 papers in SSCI and SCI high-impact factor journals, more than 50 papers in Chinese authoritative journals such as Science Bulletin and Acta Psychologica Sinica, and 6 monographs. He has presided over more than 10 projects, including the National Natural Science Foundation of China, the National Social Science Foundation of China and the Humanities and Social Science projects of the Ministry of Education. He also published Neurophysiology and Rehabilitation, Journal of Neurology & Neuroscience, Journal of Psychological Research, and Brain Editorial Board of Disorders & Therapy. His current research focuses on cognition and learning, and his research achievements mainly focus on cognitive processing and brain mechanism of children with special groups.
Porto Alegre Clinical Hospital Brazil
Will be updated soon.
Institute of Neurology and Neurosurgery Cuba
Dr. Calixto Machado graduated as MD in 1976. He continued his medical training to become a Specialist in Neurology and Clinical Neurophysiology, First Degree in 1980 and Second Degree in 1984. In 1990 he became the youngest Dr. in Sciences (Second Degree) in his country. Dr. Machado received clinical training in specialized neurology centers in Sweden, Italy, Austria, and the US. Dr. Machado has trained many medical students, neurology residents, fellows, and doctorate students in neurosciences from Cuba and the rest of the world. During the last 30 years, he has run many research protocols, such as brain death, coma, persistent vegetative states, and other disorders of consciousness, stroke, autism, autonomic nervous system, etc. He has over 450 peer-reviewed articles, book chapters, and seven books. His Book “Brain Death: A Reappraisal” has been recognized with great enthusiasm among neurologists, neurosurgeons, intensivists, and physicians specializing in transplants.
University of Petroleum and Energy Studies India
Dr. Sonali Vyas is serving as an academician and researcher for more than a decade. Currently, she is working as Assistant Professor (Selection Grade) in School of Computer Science at University of Petroleum and Energy Studies, Uttarakhand. Her research interest includes Healthcare Informatics, Blockchain, Database Virtualization, Data Mining, and Big Data Analytics. She has authored the ample number of research papers, articles and chapters in refereed journals/conference proceedings and books. She authored a book on “Smart Health Systems”, Springer. She is also an editor of “Pervasive Computing: A Networking Perspective and Future Directions”, Springer Nature and “Smart Farming Technologies for Sustainable Agricultural Development, IGI Global”. She acted as a guest editor in a special issue of “Machine Learning and Software Systems” in “Journal of Statistics & Management Systems (JSMS)” (Thomson Reuters)”. She has also authored 3 patents in the area of Smart and sustainable system. She has also acted as a Resource Person in AICTE-ISTE Faculty Refresher Course on "Embedded Systems, IoT, Pervasive Computing” and delivered many talks reputed International and National Conferences. She is also a member of Editorial Board and Reviewer Board in many referred National and International journals. She has also been a member of Organizing Committee, National Advisory Board and Technical Program Committee at many International and National conferences. She has also Chaired Sessions in various reputed International and National Conferences. She has been awarded as “National Distinguished Educator Award 2021” and “International Young Researcher Award 2021”, instituted by the “International Institute of organized Research (I2OR) which is a registered MSME, Government of India” and Green ThinkerZ. Also awarded as “Women Researcher Award 2021”, by VDGOOD Professional Association in International Conference on award winners in Engineering, Science and Medicine. Also awarded as “Best Academician of the Year Award (Female)” in "Global Education and Corporate Leadership Awards (GECL-2018)”. She is a professional member of Senior Member-IEEE, ACM-India, CSI, IFERP, IAENG, ISOC, SCRS and IJERT.
University of Gothenburg Sweden
Prof. Dr. Trevor Archer is Born: 25thOctober1949(St.Crispin’s &St.Crispinian’s day). At 7 years-of-age, I was sent to St. Joseph’s College (school), North Point, Darjeeling, and from 15-17 years I attended Wallington Grammar School, Wallington, Surrey, UK. During this latter period, I was part-time (2 days/week) stable lad, Epsom, Surrey(PaulSmythe, racehorse trainer).Withsix ‘O’-levels, I was offered a position at the Institute of Animal Physiology, Babraham, UK (1967), and took my OND and HND qualifications at Cambridgeshire Polytechnical College, Cambridge, UK (1971). Thereafter, I obtained an Honour’s degree (BSc, Psychology and Physiology) at Newcastle-upon-Tyne University (1974), and a PhD, Uppsala University, Uppsala, Sweden (1979). From 1978 (Aug) to 1988 (Dec), I was employed by Astra Läkemedel AB with the position of Head of Neuropharmacology Section and CNS Drugs when I left (1988) to take up my appointment as Professor and Chair of Biological Psychology, University of Gothenburg. I have held the position of Guest or Visiting Professor at: University of Hawaii at Manoa(1994), Örebro University(1996-2006), Karlstad University (2000-2004), Kalmar University (2003-2013), Madrid University(1991-2009), Sapienza University,Rome(2013-2019) and received an Outstanding Lifetime Achievement Award from St. Joseph’s College, North Point (October, 2010); Honorary Doctorship, Professorship and Membership Awards from the Polish Academy of Science Pharmacological Society (May, 2013); and the Sansone Award (April, 2014): School of Medicine, Washington University, St. Louis, Missouri. Dr. Waymans Mullin Award (Best Journal Article, withAC Andersson et al.), Society for Police and Criminal Psychology (2018), H-index is currently 49, with over 7880 citations, Senior professor at Gothenburg university since 30th October 2016 until 30th March 2020.
National Institute of Mental Health and Neuro Sciences India
Will be updated soon.
Shriners Hospitals Pediatric Research Center USA
Dr. Ajay Pal an Associate Scientist in the Shriners Hospitals Pediatric Research Center (Center for Neural Repair and Rehabilitation)Temple University School of Medicine, Philadelphia, PA, USA. My current work focused on the modulation of large diameter proprioceptiveafferent for the recovery of sensorimotor function after SCI. In another project I am investigating the role of cerebellar and spinocerebellar pathways in recovery of skilled forelimb function after cervical lesions in rodents. I earned amaster’s degree in biomedical sciences from University of Delhi and my interest in Neuroscience led me to earn a PhD degree in Neurophysiology from AIIMS, New Delhi followed by postdoctoral training from Clinatec Laboratory, CEA, France, and Burke Neurological Institute - Weill Cornell Medicine, New York before moving to Columbia University as a research scientist. My research at Columbia University was focuses on the interplay of brain and spinal cord in the control of skilled arm and hand function. I seek to understand how neural circuits are compromised by injury and to strengthen thebrain and spinal connections that are spared using paired motor cortex and spinal cord stimulation, to improve recovery.My research focused towards furthering our knowledge of spinal injuries and the treatment of paralysis due to a variety of causes. Will be updated soon...